The Eversense 365 is an implantable CGM sensor for adults that provides continuous glucose monitoring with a sensor life of up to 12 months. The pill-sized sensor is placed just under the skin in the upper arm while the rechargeable, water-resistant, removable transmitter sits on top of the skin and wirelessly sends data to compatible smart devices.
The transmitter also provides vibrating on-body alerts when glucose hits a customizable preset high or low level, even when the smart device is not in range. Predictive alerts help users know if glucose is trending high or low. Eversense is the only CGM sensor approved for use during an MRI (transmitter must be temporarily removed).
Using the Eversense Now app, up to five caregivers can view real-time glucose readings and receive alerts on compatible smart devices. The transmitter must be charged daily for 15 minutes. The rechargeable transmitter is secured to skin with a disposable adhesive patch that is changed daily.
Series of four fingerstick calibrations initially within 6–36 hours, then once-daily calibration for the first 13 days, followed by once per week calibration. No finger-stick confirmation is required when making treatment decisions.
Eversense 365 is approved for age 18 and older. It is not approved for use during pregnancy.
Looking for a different way to manage diabetes care? Browse and compare information on the latest devices, tools, and technology.